Petct in Cancer of Unknown Primary

This book aims to examine all immunohistochemical and molecular pathological biomarkers that can be useful and effective in patient diagnosis, prognosis and treatment decision, especially when faced with a carcinoma of unknown primary.

This book aims to examine all immunohistochemical and molecular pathological biomarkers that can be useful and effective in patient diagnosis, prognosis and treatment decision, especially when faced with a carcinoma of unknown primary.

This book aims to examine all immunohistochemical and molecular pathological biomarkers that can be useful and effective in patient diagnosis, prognosis and treatment decision, especially when faced with a carcinoma of unknown primary.

Coagulation in Cancer informs medical professionals working in the field of cancer of the pathophysiologic mechanisms of cancer-related thrombosis and bleeding. It provides assistance in recognizing the various bleeding and clotting disorders associated with cancer and includes current recommendations for the management of hemorrhage, and prevention and treatment of thrombosis in the patient with malignancy.

The focus of this book is to describe the current understanding of the interactions between the nervous system and cancer and the use of this information in the treatment and prevention of cancer. Author and noted researcher Boris Mravec presents a clearly written and well-illustrated monograph on this rapidly developing new field. The book begins with an exploration of the basic concepts supporting the neurobiology of cancer, discusses the ways in which the nervous system affects all the hallmarks of cancer, delves extensively into stress and cancer, covers the etiopathogenetic consequences of the neurobiology of cancer, the implications for cancer prevention and treatment, and looks at future directions in the field.